Obesity, weight management, healthy diets, unhealthy foods are all matters of high concern nowadays. We either struggle to stay fit or try to lose weight with very strict diets that usually get us nowhere. The truth is that it is extremely challenging to keep our bodies fit nowadays, with all the junk food out there and with all the rush that keeps us away from cooking a decent meal for ourselves.
Obese people who have long struggled with maintaining a balanced weight could be helped by a new device that has proved to be highly efficient in previous trials: a balloon device recently approved by the American Food and Drug Administration.
Gastric balloon devices are already a highly popular weight loss treatment in many countries such as the UK. They work by physically taking up space in the stomach in order to create the sensation of fullness earlier than usual. This method acts efficiently by limiting appetite.
Balloon devices have been ignored by officials in the US until now, although they are considered relatively safe. Their effectiveness is limited by the balloon’s duration inside the stomach. Once the balloon is removed, the person is extremely exposed to return to the same lifestyle habits before the device was put in place and thus regain the weight.
However, the latest version of the balloon device comes with advanced characteristics that bring a greater set of benefits and a lower chance to regain the weight that was previously taken off. There are actually two connected balloons, which means that the device is able to expand more while remaining extremely flexible to the shape and contour of the stomach. The ReShape device is also less exposed to accidentally deflate and end up in the intestine. Previous other versions had this flaw in the system which apparently has been solved with a revamp. Patients are not anymore at risk to have their arteries blocked, as ReShape is completely safe compared to previous versions.
According to extended studies performed on patients who had a ReShape intervention, 187 of 326 analyzed have managed to lose an average of 14.3 pounds, compared to 7.2 pounds for a control group gathered together by a team of experts. In a randomized and controlled clinical trial of the treatment that run for a year, both groups were subjected to exercise and diet counseling. The control group was tricked to believe that they had received the device by being given a similar 30 minute outpatient procedure as the active group had been given, but they were not actually implanted with it. After actual removal, the patients maintained 10 pounds on average of their weight loss. This is not the most successful study, as other interventions, trials and analysis initiatives have proven to be more successful in the past.
Image Source: article.wn.com